EQL Pharma AB (publ) (STO:EQL)
Sweden · Delayed Price · Currency is SEK 20.60
+0.05 (0.24%)
At close: Jul 24, 2026
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 608.31 million as of July 24, 2026. Its market cap has decreased by -77.05% in one year.
Market Cap
608.31M
Enterprise Value
980.89M
Revenue
432.66M
Ranking
n/a
PE Ratio
49.05
Stock Price
20.60
ChartMarket Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 608.31M, an increase of 677.67%. That is a compound annual growth rate of 17.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 608.31M | -64.36% |
| Dec 30, 2025 | 1.71B | -27.50% |
| Dec 30, 2024 | 2.35B | 142.51% |
| Dec 29, 2023 | 970.72M | 16.78% |
| Dec 30, 2022 | 831.22M | -26.29% |
| Dec 30, 2021 | 1.13B | -2.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.69B |
| Cereno Scientific AB | 1.54B |
| Nanexa AB | 678.17M |
| Dicot Pharma AB | 622.98M |
| Cinclus Pharma Holding AB | 555.66M |
| Orexo AB | 532.21M |
| Enzymatica AB | 456.34M |
| Moberg Pharma AB | 438.52M |